Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 5 Barrett Esophagus 3 Pancreatic Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Stomach Neoplasms 1 Liver Neoplasms 1 Liver Cirrhosis 1 Fibrosis 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breath Test 1 Breast Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 55 Carboplatin 50 pembrolizumab 42 Paclitaxel 42 Gemcitabine 28 Pemetrexed 23 Radiotherapy 21 Magnetic Resonance Spectroscopy 20 Radiotherapy, Intensity-Modulated 18 Cetuximab 18 Docetaxel 17 Specimen Handling 16 Nivolumab 16 Fluorouracil 16 Cyclophosphamide 14 durvalumab 13 Bevacizumab 13 Sorafenib 12 Radiation 11 130-nm albumin-bound paclitaxel 11 Sunitinib 10 Platinum 10 1,2-diaminocyclohexaneplatinum II citrate 10 osimertinib 9 Oxaliplatin 8 Irinotecan 8 Ipilimumab 8 Everolimus 8 Drug Therapy 8 Capecitabine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Breath Tests × Clear all

NCT04419207 2022-04-20

Detecting Lung Cancer Based on Exhaled Breath

Peking University People's Hospital

Carcinoma, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡